These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 30573692)

  • 1. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
    Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
    Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
    Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
    Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma.
    Jin Y; Qin X
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
    Wicker CA; Takiar V; Suganya R; Arnold SM; Brill YM; Chen L; Horbinski CM; Napier D; Valentino J; Kudrimoti MR; Yu G; Izumi T
    Oral Oncol; 2020 Dec; 111():104949. PubMed ID: 32801084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.
    Li M; Li A; Zhou S; Xu Y; Xiao Y; Bi R; Yang W
    BMC Cancer; 2018 Jan; 18(1):4. PubMed ID: 29291717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment.
    Kim DH; Ahn JS; Kang M; Park G; Lim Y; Hwang S; Ock CY; Koh J; Chung EJ; Kwon SK; Jeon YK; Jung KC; Ahn SH; Keam B
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
    Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS
    Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
    Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
    Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
    Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
    Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
    Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma.
    Holt J; Walter V; Yin X; Marron D; Wilkerson MD; Choi HY; Zhao X; Jo H; Hayes DN; Ko YH
    Clin Cancer Res; 2021 Feb; 27(3):831-842. PubMed ID: 33148669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Occult Lymph Node Metastasis in Head and Neck Cancer with CD31 Vessel Quantification.
    Mermod M; Bongiovanni M; Petrova T; Goun E; Simon C; Tolstonog G; Monnier Y
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):277-283. PubMed ID: 30084319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction score for lymph node metastasis from cutaneous squamous cell carcinoma of the external ear.
    Wermker K; Kluwig J; Schipmann S; Klein M; Schulze HJ; Hallermann C
    Eur J Surg Oncol; 2015 Jan; 41(1):128-35. PubMed ID: 25182221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles.
    Mastronikolis NS; Delides A; Kyrodimos E; Piperigkou Z; Spyropoulou D; Giotakis E; Tsiambas E; Karamanos NK
    Mol Biol Rep; 2024 Apr; 51(1):597. PubMed ID: 38683372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
    Wang S; Chen X; Qiao T
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel signature derived from single cell RNA-sequencing for preoperative prediction of lymph node metastasis in head and neck squamous cell carcinoma.
    Dai Y; Wang Z; Yan E; Li J; Ge H; Xiao N; Cheng J; Diao P
    Head Neck; 2022 Oct; 44(10):2171-2180. PubMed ID: 35726502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.